Chugai Pharmaceutical Co., Ltd. (4519)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Mar 13, 2025

$46.48

P/E Ratio

29.47

Market Cap

$76.43B

Mar 25, 2024Apr 26, 2024Jun 3, 2024Jul 2, 2024Aug 2, 2024Sep 5, 2024Oct 9, 2024Nov 13, 2024Dec 17, 2024Jan 27, 2025Mar 13, 2025$20.00$30.00$40.00$50.00$60.00
  • 4519
Description
Add to research

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Metrics
Add to research

Overview

  • HQTokyo, TY
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • Ticker4519
  • Price$46.48302-0.54%

Trading Information

  • Market cap$76.43B
  • Float37.27%
  • Average Daily Volume (1m)2,444,489
  • Average Daily Volume (3m)2,123,463
  • EPS$235.39

Company

  • Revenue$1.17T
  • Rev growth (1yr)5.33%
  • Net income$387.32B
  • Gross margin71.01%
  • EBITDA margin48.81%
  • EBITDA$571.33B
  • EVN/A
  • EV/RevenueN/A
  • P/E29.47
  • P/S9.75
  • P/B6.00
  • Debt/EquityN/A
Documents
Add to research